Navigation Links
CM Glucose Broth from Aestus Pharmaceuticals Corp.

ProductsCM Glucose Broth from Aestus Pharmaceuticals Corp.
Company Aestus Pharmaceuticals Corp.
Item CM Glucose Broth
Price $132.00
Description Growth Medium / Media
Info Aestus Pharmaceuticals Corp.Aestus Pharmaceuticals Corp.
1041 Fox Glen Drive
Watkinsville, GA 30677
USA

Call Aestus Pharmaceuticals Corp. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-231-9886
Customer Service: 800-449-6809
Fax Number: 800-886-4025
Web Site: http://www.aestuspharm.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. YSI 2300 STAT Plus Glucose & Lactate Analyzer from YSI Incorporated
2. Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
3. Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
4. Glucose Colorimetric Assay Kit, QuantiChrom from BioAssay Systems
5. Goat Anti-Bacillus species Glucose Dehydrogenase Polyclonal Antibody, Unconjugated from Abcam
6. CM Galactose Broth from Aestus Pharmaceuticals Corp.
7. LB Broth Base powder (Lennox L Broth Base) from Invitrogen
8. LB Broth Base powder (Lennox L Broth Base) from Invitrogen
9. (Millers LB Broth Base) Luria Broth Base powder from Invitrogen
10. Terrific Broth from GE Healthcare, formerly Amersham Biosciences
11. Water, USP Purified/WFI G from Aestus Pharmaceuticals Corp.
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Mycoplasma and virus tested...
... MagicMark XP Western Protein Standards are ... protein molecular weight estimation directly on ... an IgG binding site, allowing direct ... used to detect your target protein ...
... Clone/PAD: 3F10B10. Immunogen: Synthetic ... region of JAB1 (Jun activation ... Specificity: Specific for the JAB1 ... controls: 293T Jurkat cell lysates). ...
Biology Products:
(Date:8/31/2014)... new study of satellite data from the last 19 years ... sea-level around the coast of Antarctica to rise by 2cm ... the University of Southampton detected the rapid rise in sea-level ... than a million square kilometres. , The melting ... ice shelves has contributed an excess of around 350 gigatonnes ...
(Date:8/31/2014)... CAMBRIDGE, MA -- Over the past several decades, malaria diagnosis ... a patient, a technician smears the blood across a glass ... a microscope for the Plasmodium parasite, which causes the disease. ... are in the blood an important measure of disease ... for human error. , A research team from the Singapore-MIT ...
(Date:8/29/2014)... UC Davis have made some surprising discoveries about ... simian immunodeficiency virus (SIV), the team found that ... are early responders to viral invasion and are ... cytokine called interleukin-1 beta (IL-1β). , Though ... breakdown of the gut epithelium that provides a ...
Breaking Biology News(10 mins):A new way to diagnose malaria 2A new way to diagnose malaria 3The early cost of HIV 2
... eastern Pacific populations of leatherback turtles, the 21st century ... change could exacerbate existing threats and nearly wipe out ... nests buried at hotter, drier beaches are the leading ... a new study in the journal Nature Climate ...
... 2012 Scientists at The Scripps Research Institute have discovered ... within cells. The scientists highlighted the medical potential of the ... to an experimental gene therapy against HIV infection. "We ... the troubles that have long been linked to traditional gene ...
... highly valued, highly cited research and reviews to the ... report that the new impact factors align with community ... the highest impact research and reviews in the biomedical ... by Thomas Reuters. Cell Press,s flagship journal ...
Cached Biology News:Rising heat at the beach threatens largest sea turtles, climate change models show 2Rising heat at the beach threatens largest sea turtles, climate change models show 3Scripps Research Institute Scientists Develop Alternative to Gene Therapy 2Scripps Research Institute Scientists Develop Alternative to Gene Therapy 3Scripps Research Institute Scientists Develop Alternative to Gene Therapy 4Cell Press journals continue to deliver high impact 2Cell Press journals continue to deliver high impact 3
(Date:8/29/2014)... Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company ... to manufacture proteins including biosimilar therapeutics, today provided ... the second quarter ended June 30, 2014. ... public offering, we have the capital to continue ... our proprietary protein expression platform," stated Bertrand C. ...
(Date:8/29/2014)... VANCOUVER , Aug. 29, 2014 /PRNewswire/ - ... (OTCQX: ICOTF), today reported financial results for the ... specified otherwise, are expressed in Canadian dollars and ... Second Quarter 2014 Highlights , ... visual acuity (VA) primary endpoint for subjects enrolled ...
(Date:8/29/2014)... San Antonio, TX (PRWEB) August 29, 2014 ... 9001:2008 and ISO 13485:2003 certified, GAMP® 5 compliant ... been awarded an international Phase II clinical trial ... non-Hodgkin’s lymphoma. , Throughout this trial, Intrinsic Imaging ... but not limited to, protocol and charter development, ...
(Date:8/28/2014)... Ind. A new research platform uses ... of tiny structures undergoing stress and heating, ... improve designs for microelectronics and batteries., This ... information about how heating and the surface ... properties. Researchers have discussed the merits of ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3